Hypertrichosis of the Upper Cheek Area Associated With Travoprost Treatment of Glaucoma : Ophthalmic Plastic & Reconstructive Surgery

Secondary Logo

Journal Logo

Advanced Search
Brief Reports

Hypertrichosis of the Upper Cheek Area Associated With Travoprost Treatment of Glaucoma

Ortiz-Perez, Santiago M.D.; Olver, Jane M. F.R.C.Ophth.

Author Information

Oculoplastic and Orbital Service, Western Eye Hospital and the Eye Department, Charing Cross, London, United Kingdom

Accepted for publication November 9, 2009.

None of the authors disclose any type of financial interest related to the manuscript.

Address correspondence and reprint requests to Jane M. Olver, F.R.C.Ophth., Western Eye Hospital, Marylebone Road, London NW1 5QH, United Kingdom. E-mail: [email protected].

Ophthalmic Plastic & Reconstructive Surgery 26(5):p 376-377, September 2010. | DOI: 10.1097/IOP.0b013e3181cbfbdd

Abstract

Travoprost is a prostaglandin analog used in the treatment of open-angle glaucoma. This drug is safe and efficacious and has a low incidence of systemic and local side effects. Common local side effects are conjunctival hyperemia, iris pigmentation, and hypertrichosis of the eyelashes. The authors present a case of a patient who developed marked hypertrichosis of the cheek vellus 3 months after starting treatment with travoprost.

©2010The American Society of Opthalmic Plastic and Reconstructive Surgery, Inc.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid